MobiHealth News April 26, 2024
The pharma giant’s employees will have access to ChatGPT Enterprise, which allows teams to create customized GPTs on specific topics.
OpenAI and Moderna announced the pair have expanded their partnership to offer the pharma giant’s employees access to ChatGPT Enterprise, a platform that allows customizable GPTs to be developed for a specific purpose.
Through ChatGPT Enterprise, users can create GPTs by beginning a conversation with ChatGPT, then providing extra knowledge on a subject or giving it instructions. Users can also choose what the GPT can do, such as analyzing data, searching the web or making images.
Moderna, which initially partnered with OpenAI in early 2023, tested the deployment of ChatGPT Enterprise within its workforce, allowing individual teams to...